PDK2 and ovarian clear cell cancer: Sachiko et al. found that high PDK2 expression was associated with a poor prognosis and that inhibiting PDK2 increased cisplatin sensitivity by activating the electron transport chain and increasing the generation of mitochondrial reactive oxygen species in Ovarian clear cell carcinoma [22].